A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023.
Jeenah Moon | The Washington Post | Getty Images
A highly popular group of weight loss and diabetes drugs is decreasing some consumers’ appetites — and also how much they spend on food.
Most people taking those medications, called GLP-1s, say they are spending less on eating out at restaurants and ordering takeout, according to a Morgan Stanley survey released on Tuesday. A smaller share of those surveyed say they are tightening their purse strings in the grocery store.
The findings add to the mounting concerns that soaring demand for GLP-1s could take a bite out of the bottom lines of some of the biggest restaurant companies and makers of packaged snacks like Doritos, Oreos and Hershey’s Kisses. GLP-1s include Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes…
